LONG BRANCH, N.J., Feb. 14, 2011 /PRNewswire/ -- Pharma ChemOutsourcing today launched its 2011 show with the unveiling of the first wave of 50 speakers from a diverse array of biotechnology companies pursuing small molecule drug discovery.
"The biotechs all have clinical pipelines and their experiences in managing R&D programs with limited capital and human resources demonstrate how they have emerged as the new drug discovery engine," said Mark Alexay, the event organizer. "Their low-cost business model means they outsource everything except their IP." The speaker list may be found at http://chemoutsourcing.com/speakers.php
"This year only we have implemented a special rate to make the show accessible for all biotechs," continued Alexay. "Our ultimate goal is to attract chemists from every biotech and medium-sized pharmaceutical company in the world. To that end we will continue to create very special annual gatherings to meet their needs." Further pharma and biotech special rate information may be found at http://chemoutsourcing.com/biotech.php
"We already have great relations with the Big Pharma companies like Pfizer, Merck, Bristol-Myers Squibb, and Eli Lilly all of whom we work closely with. In 2011 our efforts are increasingly focused on the members of state biotech association members like those of BioNJ, PA Bio, MassBio, BayBio, and SoCalBio. The US biotech industry is the world leader - facilitating quality interactions among its leaders is good for business."
Pharma ChemOutsourcing is the annual conference and exhibition focused on US, European, and Asian Sourcing/Outsourcing, Medicinal Chemistry, Process R&D, Chemical Development, Formulation, Finished Products, and new chemical technologies, such as flow chemistry. China's entry into drug discovery collaborations is o
|SOURCE Pharma ChemOutsourcing|
Copyright©2010 PR Newswire.
All rights reserved